🔖
Cite This Article
DANIŞ, N., TEKİN, F. (2019). Eicosapentaenoic acid and aspirin for colorectal adenomas. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 2, 213–214. https://ajindex.com/articles/408801
Journals / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 2
Eicosapentaenoic acid and aspirin for colorectal adenomas
- Pages
- 213–214
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (1)
- Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging 2016; 11: 967-76. [CrossRef] Amerci F, Agustin M, Ko CY. Colorectal cancer: epidemiology, risk factors, and health services. Clin Colon Rectal Surg 2005; 18: 133- 40. [CrossRef] West NJ, Clark SK, Phillips RK, et al. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 2010; 59: 918-25. [CrossRef] Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 2009; 101: 256-66. [CrossRef] Hull MA, Sprange K, Hepburn T, et al. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2x2 factorial trial. Lancet 2018; 392: 2583-94. [CrossRef]